NP35925 Cardiovascular & Respiratory Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Contract (Goods)
Duration
not specified
Value
£14K-£30M
Sector
HEALTH
Published
06 May 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 85 suppliers

Description

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Division

2 Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

3 Epinephrine (Adrenaline) Pre-Filled Syringes

Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

5 Enoxaparin Sodium Injection

Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

7 Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets

Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

8 Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets

Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

9 Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets

Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

10 Nifedipine Modified-Release (M/R) Capsules and Tablets

Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

12 Branded and Branded Generic Inhalers

Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

13 Iloprost Medicines

Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

14 Dalteparin Injections

Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

15 Tinzaparin Sodium Injections

Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

16 Icatibant Solution for Injection

Supply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

17 Treprostinil Injection

Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

18 Direct Acting Oral Anticoagulants (DOACs)

Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

19 All Other Cardiovascular & Respiratory Medicines

Supply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.

Award Detail

1 Martindale Pharma (Romford)
  • Epinephrine (Adrenaline) Pre-Filled Syringes
  • Reference: 019020-2025-1
  • Value: £1,575,630 [share]
  • Awarded to group of suppliers.
2 Aguettant (Bristol)
  • Epinephrine (Adrenaline) Pre-Filled Syringes
  • Reference: 019020-2025-1
  • Value: £1,575,630 [share]
  • Awarded to group of suppliers.
3 Glaxosmithkline (Brentford)
  • Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials
  • Reference: 019020-2025-2
  • Value: £10,789,555
4 Aventis Pharma (Guildford)
  • Enoxaparin Sodium Injection
  • Reference: 019020-2025-3
  • Value: £9,947,020 [share]
  • Awarded to group of suppliers.
5 Day Lewis Medical (Croydon)
  • Enoxaparin Sodium Injection
  • Reference: 019020-2025-3
  • Value: £9,947,020 [share]
  • Awarded to group of suppliers.
6 Techdow Pharma England (Guildford)
  • Enoxaparin Sodium Injection
  • Reference: 019020-2025-3
  • Value: £9,947,020 [share]
  • Awarded to group of suppliers.
7 Venipharm (Gerrards Cross)
  • Enoxaparin Sodium Injection
  • Reference: 019020-2025-3
  • Value: £9,947,020 [share]
  • Awarded to group of suppliers.
8 Martindale Pharma (Romford)
  • Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-4
  • Value: £53,405 [share]
  • Awarded to group of suppliers.
9 Accord (London)
  • Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-4
  • Value: £53,405 [share]
  • Awarded to group of suppliers.
10 Chiesi (Manchester)
  • Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-4
  • Value: £53,405 [share]
  • Awarded to group of suppliers.
11 Mercury Pharmaceuticals (London)
  • Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-4
  • Value: £53,405 [share]
  • Awarded to group of suppliers.
12 Stada UK Thornton & Ross (Huddersfield)
  • Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-4
  • Value: £53,405 [share]
  • Awarded to group of suppliers.
13 Martindale Pharma (Romford)
  • Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-5
  • Value: £81,720 [share]
  • Awarded to group of suppliers.
14 Aventis Pharma (Guildford)
  • Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-5
  • Value: £81,720 [share]
  • Awarded to group of suppliers.
15 Stada UK Thornton & Ross (Huddersfield)
  • Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-5
  • Value: £81,720 [share]
  • Awarded to group of suppliers.
16 Day Lewis Medical (Croydon)
  • Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-5
  • Value: £81,720 [share]
  • Awarded to group of suppliers.
17 Selective Supplies (Haywards Heath)
  • Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-6
  • Value: £37,695
18 Accord (London)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
19 Aspire (Elgin)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
20 Chiesi (Manchester)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
21 CST Pharma (Walsall)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
22 Day Lewis Medical (Croydon)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
23 Glenmark Pharmaceuticals Europe (Watford)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
24 Kent Pharmaceuticals (Ashford)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
25 Sandoz (Surrey)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
26 Selective Supplies (Haywards Heath)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
27 Stada UK Thornton & Ross (Huddersfield)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
28 Wockhardt (Wrexham)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
29 Glaxosmithkline (Brentford)
  • Branded and Branded Generic Inhalers
  • Reference: 019020-2025-7
  • Value: £2,961,460 [share]
  • Awarded to group of suppliers.
30 Colonis Pharma (Royal Tunbride Wells)
  • Iloprost Medicines
  • Reference: 019020-2025-8
  • Value: £257,595 [share]
  • Awarded to group of suppliers.
31 Zentiva Pharma (London)
  • Iloprost Medicines
  • Reference: 019020-2025-8
  • Value: £257,595 [share]
  • Awarded to group of suppliers.
32 Pfizer (Tadworth)
  • Dalteparin Injections
  • Reference: 019020-2025-9
  • Value: £30,489,875
33 Northumbria Healthcare NHS Trust (Newcastle upon Tyne)
  • Tinzaparin Sodium Injections
  • Reference: 019020-2025-10
  • Value: £848,290
34 Martindale Pharma (Romford)
  • Icatibant Solution for Injection
  • Reference: 019020-2025-11
  • Value: £170,315 [share]
  • Awarded to group of suppliers.
35 Celix Pharma (London)
  • Icatibant Solution for Injection
  • Reference: 019020-2025-11
  • Value: £170,315 [share]
  • Awarded to group of suppliers.
36 Glenmark Pharmaceuticals Europe (Watford)
  • Icatibant Solution for Injection
  • Reference: 019020-2025-11
  • Value: £170,315 [share]
  • Awarded to group of suppliers.
37 Hikma Pharmaceutical (London)
  • Icatibant Solution for Injection
  • Reference: 019020-2025-11
  • Value: £170,315 [share]
  • Awarded to group of suppliers.
38 Stada UK Thornton & Ross (Huddersfield)
  • Icatibant Solution for Injection
  • Reference: 019020-2025-11
  • Value: £170,315 [share]
  • Awarded to group of suppliers.
39 Wockhardt (Wrexham)
  • Icatibant Solution for Injection
  • Reference: 019020-2025-11
  • Value: £170,315 [share]
  • Awarded to group of suppliers.
40 DR Reddys Laboratories (Cambridge)
  • Treprostinil Injection
  • Reference: 019020-2025-12
  • Value: £223,250
41 Aspire (Elgin)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
42 Celix Pharma (London)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
43 Glenmark Pharmaceuticals Europe (Watford)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
44 MSN Labs (Letchworth Garden City)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
45 Perennial Pharma (Hatfield)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
46 Sandoz (Surrey)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
47 Stada UK Thornton & Ross (Huddersfield)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
48 Viatris UK Healthcare (Hatfield)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
49 Wockhardt (Wrexham)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
50 Zentiva Pharma (London)
  • Direct Acting Oral Anticoagulants (DOACs)
  • Reference: 019020-2025-13
  • Value: £446,140 [share]
  • Awarded to group of suppliers.
51 Martindale Pharma (Romford)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
52 Accord (London)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
53 Aguettant (Bristol)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
54 Aspire (Elgin)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
55 Aventis Pharma (Guildford)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
56 Bowmed Ibisqus (Wrexham)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
57 Bristol Laboratories (Berkhamsted)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
58 Colonis Pharma (Royal Tunbride Wells)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
59 Consilient Health (Richmond)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
60 CST Pharma (Walsall)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
61 Day Lewis Medical (Croydon)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
62 Focus Pharmaceuticals (Burton upon Trent)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
63 Galvany Pharma (Stevenage)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
64 Gennisium Pharma Sas (Vitrolles)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
65 Glenmark Pharmaceuticals Europe (Watford)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
66 Grindeks Kalceks (Norwich)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
67 Hameln Pharma (Gloucester)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
68 Hikma Pharmaceutical (London)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
69 Kent Pharmaceuticals (Ashford)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
70 Macure Pharma Aps (København Nv)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
71 Mercury Pharmaceuticals (London)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
72 Morningside Pharmaceuticals (Leicester)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
73 MSN Labs (Letchworth Garden City)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
74 Pfizer (Tadworth)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
75 Ranbaxy (London)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
76 Rosemont Pharmaceuticals (Leeds)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
77 Sandoz (Surrey)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
78 Stirling Anglian Pharmaceuticals (Glasgow)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
79 Syrimed (Kingston upon Thames)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
80 Stada UK Thornton & Ross (Huddersfield)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
81 Viatris UK Healthcare (Hatfield)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
82 Wockhardt (Wrexham)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
83 Zentiva Pharma (London)
  • All Other Cardiovascular & Respiratory Medicines
  • Reference: 019020-2025-14
  • Value: £24,410,075 [share]
  • Awarded to group of suppliers.
84 Focus Pharmaceuticals (Burton upon Trent)
  • Nifedipine Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-15
  • Value: £13,855 [share]
  • Awarded to group of suppliers.
85 Stada UK Thornton & Ross (Huddersfield)
  • Nifedipine Modified-Release (M/R) Capsules and Tablets
  • Reference: 019020-2025-15
  • Value: £13,855 [share]
  • Awarded to group of suppliers.

Award Criteria

Logistics 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty six (36) month contract duration and the twenty four (24) month extension period of the framework agreement. (SC Ref:795893)

Reference

Domains